272 related articles for article (PubMed ID: 27999253)
1. Treatment of Post-Traumatic Stress Disorder Nightmares at a Veterans Affairs Medical Center.
Detweiler MB; Pagadala B; Candelario J; Boyle JS; Detweiler JG; Lutgens BW
J Clin Med; 2016 Dec; 5(12):. PubMed ID: 27999253
[TBL] [Abstract][Full Text] [Related]
2. Risperidone for post-traumatic combat nightmares: a report of four cases.
Detweiler MB; Khachiyants N; Detweiler JG; Ali R; Kim KY
Consult Pharm; 2011 Dec; 26(12):920-8. PubMed ID: 22155575
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in U.S. military veterans.
Breen A; Blankley K; Fine J
J Am Assoc Nurse Pract; 2017 Feb; 29(2):65-69. PubMed ID: 27977074
[TBL] [Abstract][Full Text] [Related]
4. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.
Raskind MA; Thompson C; Petrie EC; Dobie DJ; Rein RJ; Hoff DJ; McFall ME; Peskind ER
J Clin Psychiatry; 2002 Jul; 63(7):565-8. PubMed ID: 12143911
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Management of Nightmares Associated with Posttraumatic Stress Disorder.
Geldenhuys C; van den Heuvel LL; Steyn P; Seedat S
CNS Drugs; 2022 Jul; 36(7):721-737. PubMed ID: 35688992
[TBL] [Abstract][Full Text] [Related]
6. Prazosin for treatment of nightmares related to posttraumatic stress disorder.
Taylor HR; Freeman MK; Cates ME
Am J Health Syst Pharm; 2008 Apr; 65(8):716-22. PubMed ID: 18387899
[TBL] [Abstract][Full Text] [Related]
7. Prazosin for Trauma Nightmares and Sleep Disturbances in Combat Veterans with Post-Traumatic Stress Disorder.
Khazaie H; Nasouri M; Ghadami MR
Iran J Psychiatry Behav Sci; 2016 Sep; 10(3):e2603. PubMed ID: 27822278
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological management of post-traumatic stress disorder and its associated nightmares: A survey of psychiatrists.
Martin A; Kosari S; Peterson GM; Thomas J; Morris P; Naunton M
J Clin Pharm Ther; 2021 Feb; 46(1):158-165. PubMed ID: 33026676
[TBL] [Abstract][Full Text] [Related]
9. The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases.
Raskind MA; Dobie DJ; Kanter ED; Petrie EC; Thompson CE; Peskind ER
J Clin Psychiatry; 2000 Feb; 61(2):129-33. PubMed ID: 10732660
[TBL] [Abstract][Full Text] [Related]
10. Correlates of Nonimprovement to Pharmacotherapy for Chronic, Antidepressant-Resistant, Military Service-Related Posttraumatic Stress Disorder: Insights From the Veterans Affairs Cooperative Study No. 504.
Byrne SP; Krystal JH; Rosenheck RA; Vessicchio J; Pietrzak RH;
J Clin Psychopharmacol; 2017 Dec; 37(6):717-721. PubMed ID: 28945664
[TBL] [Abstract][Full Text] [Related]
11. Clinical case series: the use of Prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans.
Daly CM; Doyle ME; Radkind M; Raskind E; Daniels C
Mil Med; 2005 Jun; 170(6):513-5. PubMed ID: 16001603
[TBL] [Abstract][Full Text] [Related]
12. Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety.
Byers MG; Allison KM; Wendel CS; Lee JK
J Clin Psychopharmacol; 2010 Jun; 30(3):225-9. PubMed ID: 20473055
[TBL] [Abstract][Full Text] [Related]
13. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.
Raskind MA; Peskind ER; Hoff DJ; Hart KL; Holmes HA; Warren D; Shofer J; O'Connell J; Taylor F; Gross C; Rohde K; McFall ME
Biol Psychiatry; 2007 Apr; 61(8):928-34. PubMed ID: 17069768
[TBL] [Abstract][Full Text] [Related]
14. A retrospective chart review to determine the safety and efficacy of prazosin for nightmares related to posttraumatic stress disorder in veterans.
Diokpa C; Backe K; Pinsonnault J
Hum Psychopharmacol; 2021 Sep; 36(5):e2785. PubMed ID: 33751692
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal relationships of insomnia, nightmares, and PTSD severity in recent combat veterans.
Pigeon WR; Campbell CE; Possemato K; Ouimette P
J Psychosom Res; 2013 Dec; 75(6):546-50. PubMed ID: 24290044
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection.
Mohamed S; Rosenheck RA
J Clin Psychiatry; 2008 Jun; 69(6):959-65. PubMed ID: 18588361
[TBL] [Abstract][Full Text] [Related]
17. Tracing the flow of knowledge: geographic variability in the diffusion of prazosin use for the treatment of posttraumatic stress disorder nationally in the Department of Veterans Affairs.
Harpaz-Rotem I; Rosenheck RA
Arch Gen Psychiatry; 2009 Apr; 66(4):417-21. PubMed ID: 19349311
[TBL] [Abstract][Full Text] [Related]
18. Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review.
Roepke S; Danker-Hopfe H; Repantis D; Behnia B; Bernard F; Hansen ML; Otte C
Pharmacopsychiatry; 2017 Jan; 50(1):26-31. PubMed ID: 27276365
[No Abstract] [Full Text] [Related]
19. Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504.
Krystal JH; Pietrzak RH; Rosenheck RA; Cramer JA; Vessicchio J; Jones KM; Huang GD; Vertrees JE; Collins J; Krystal AD;
J Clin Psychiatry; 2016 Apr; 77(4):483-91. PubMed ID: 26890894
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
